Bristol-Myers Squibb Up 1% on New Drug Applications

Recently, Bristol-Myers Squibb (BMY)  submitted new drug applications to the U.S. Food and Drug Administration (FDA).

 

 

Related posts

Top

Warren Buffett's Best Picks

Warren Buffett's these stock picks will crush the market over the next 12 months. Get our report FREE by becoming a member now